Last reviewed · How we verify
NCT07118501
A Prospective, Post-Market, Clinical Follow-up Study of the Incompass™ Total Ankle System
trial testing Total Ankle Replacement in Post Traumatic Arthritis in 200 participants. Currently enrolling.
30 September 2030
Quick facts
| Lead sponsor | Stryker Trauma and Extremities |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 6 February 2026 |
| Primary completion | 30 September 2030 |
| Estimated completion | 1 September 2038 |
| Sites | 4 locations across United States |
Drugs / interventions tested
- Total Ankle Replacement
Conditions studied
- Post Traumatic Arthritis — all drugs for Post Traumatic Arthritis →
- Osteoarthritis — all drugs for Osteoarthritis →
- Total Ankle Replacement — all drugs for Total Ankle Replacement →
- Total Ankle Prosthesis — all drugs for Total Ankle Prosthesis →
Sponsor
Stryker Trauma and Extremities — full company profile →
Who can join
21 and older, any sex, with Post Traumatic Arthritis or Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study is to demonstrate the safety and performance of the Incompass™ Total Ankle System after surgery over the standard follow-up period. The study will measure improvements in patient-reported information related to quality of life and pain following surgery. In order to do this, medical imaging (i.e. X-Rays, CT scans) which have been taken as part of routine care, will be reviewed. Any additional X-Rays conducted during the period of the research will also be reviewed. The Incompass™ Total Ankle System has been cleared by the Food and Drug Administration (FDA). The products are already in use routinely in ankle replacement surgeries. No part of this study is experimental.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07118501
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Total Ankle Replacement
Trials testing the same drug.
- NCT05562154 — Lateral Approach Versus Anterior Approach in Total Ankle Replacement · NA · withdrawn
Other Stryker Trauma and Extremities trials
Trials by the same sponsor.
- NCT06080412 — Blueprint® Mixed Reality Pilot Study · completed
- NCT06829667 — Retrospective Study of Suture Tape for Soft Tissue Reconstruction in Patients Suffering From Lateral Ankle Instability · enrolling by invitation
- NCT05773352 — Perform® Humeral System - Fracture Study (PFX) · active not recruiting
- NCT06638138 — Study of Artelon FLEXBAND® for Patients Undergoing Soft Tissue Reconstruction of the Anterior Talofibular Ligament (ATFL · NA · enrolling by invitation
- NCT05523635 — Post Market Clinical Evaluation of Gamma 4 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07118501 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Stryker Trauma and Extremities
- Last refreshed: 24 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07118501.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing